34 related articles for article (PubMed ID: 28076825)
1. Spirocyclic Motifs in Natural Products.
Chupakhin E; Babich O; Prosekov A; Asyakina L; Krasavin M
Molecules; 2019 Nov; 24(22):. PubMed ID: 31744211
[TBL] [Abstract][Full Text] [Related]
2. Structure-Activity Relationship Studies and Optimization of 4-Hydroxypyridones as GPR84 Agonists.
Ieremias L; Kaspersen MH; Manandhar A; Schultz-Knudsen K; Vrettou CI; Pokhrel R; Heidtmann CV; Jenkins L; Kanellou C; Marsango S; Li Y; Bräuner-Osborne H; Rexen Ulven E; Milligan G; Ulven T
J Med Chem; 2024 Mar; 67(5):3542-3570. PubMed ID: 38381650
[TBL] [Abstract][Full Text] [Related]
3. The development of diphenyleneiodonium analogs as GPR3 agonists.
Gay EA; Harris DL; Wilson JW; Blough BE
Bioorg Med Chem Lett; 2023 Oct; 94():129427. PubMed ID: 37541631
[TBL] [Abstract][Full Text] [Related]
4. Structure-Activity Relationship Studies of Tetrahydroquinolone Free Fatty Acid Receptor 3 Modulators.
Ulven ER; Quon T; Sergeev E; Barki N; Brvar M; Hudson BD; Dutta P; Hansen AH; Bielefeldt LØ; Tobin AB; McKenzie CJ; Milligan G; Ulven T
J Med Chem; 2020 Apr; 63(7):3577-3595. PubMed ID: 32141297
[TBL] [Abstract][Full Text] [Related]
5. Exploration of Spirocyclic Derivatives of Ciprofloxacin as Antibacterial Agents.
Lukin A; Chudinov M; Vedekhina T; Rogacheva E; Kraeva L; Bakulina O; Krasavin M
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956812
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in the discovery of FFA1 receptor agonists as novel oral treatment for type 2 diabetes mellitus.
Defossa E; Wagner M
Bioorg Med Chem Lett; 2014 Jul; 24(14):2991-3000. PubMed ID: 24881568
[TBL] [Abstract][Full Text] [Related]
7. Free fatty acid receptor 1 (GPR40) agonists containing spirocyclic periphery inspired by LY2881835.
Krasavin M; Lukin A; Bagnyukova D; Zhurilo N; Zahanich I; Zozulya S; Ihalainen J; Forsberg MM; Lehtonen M; Rautio J; Moore D; Tikhonova IG
Bioorg Med Chem; 2016 Nov; 24(21):5481-5494. PubMed ID: 27647366
[TBL] [Abstract][Full Text] [Related]
8. Novel FFA1 (GPR40) agonists containing spirocyclic periphery: polar azine periphery as a driver of potency.
Krasavin M; Lukin A; Bagnyukova D; Zhurilo N; Zahanich I; Zozulya S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):29-36. PubMed ID: 27781494
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and structure-activity relationship studies of GPR40 agonists containing amide linker.
Chen T; Ning M; Ye Y; Wang K; Leng Y; Shen J
Eur J Med Chem; 2018 May; 152():175-194. PubMed ID: 29705709
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and Structure-activity relationship studies of new thiazole-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.
Li Z; Qiu Q; Xu X; Wang X; Jiao L; Su X; Pan M; Huang W; Qian H
Eur J Med Chem; 2016 May; 113():246-57. PubMed ID: 26945112
[TBL] [Abstract][Full Text] [Related]
11. The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470).
Hamdouchi C; Kahl SD; Patel Lewis A; Cardona GR; Zink RW; Chen K; Eessalu TE; Ficorilli JV; Marcelo MC; Otto KA; Wilbur KL; Lineswala JP; Piper JL; Coffey DS; Sweetana SA; Haas JV; Brooks DA; Pratt EJ; Belin RM; Deeg MA; Ma X; Cannady EA; Johnson JT; Yumibe NP; Chen Q; Maiti P; Montrose-Rafizadeh C; Chen Y; Reifel Miller A
J Med Chem; 2016 Dec; 59(24):10891-10916. PubMed ID: 27749056
[TBL] [Abstract][Full Text] [Related]
12. Polar aromatic periphery increases agonist potency of spirocyclic free fatty acid receptor (GPR40) agonists inspired by LY2881835.
Krasavin M; Lukin A; Bagnyukova D; Zhurilo N; Golovanov A; Zozulya S; Zahanich I; Moore D; Tikhonova IG
Eur J Med Chem; 2017 Feb; 127():357-368. PubMed ID: 28076825
[TBL] [Abstract][Full Text] [Related]
13. Progress in the discovery and development of small-molecule modulators of G-protein-coupled receptor 40 (GPR40/FFA1/FFAR1): an emerging target for type 2 diabetes.
Bharate SB; Nemmani KV; Vishwakarma RA
Expert Opin Ther Pat; 2009 Feb; 19(2):237-64. PubMed ID: 19441920
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
